KRYS — Krystal Biotech, Inc. stock price, charts and financials

QT75Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
336.67
-2.08-0.61%
OverviewShort InterestFilings
KRYSQT75Krystal Biotech, Inc.·NASDAQ
336.67-0.61%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 16, 20264Statement of changes in beneficial ownership
Sep 16, 20264Statement of changes in beneficial ownership
Sep 16, 20264Statement of changes in beneficial ownership
Sep 16, 20264Statement of changes in beneficial ownership
Sep 16, 20264Statement of changes in beneficial ownership
Sep 16, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 03, 20268-KCurrent report
Aug 03, 202610-QQuarterly report
Jul 21, 20268-KCurrent report
Jun 26, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
May 27, 20264Statement of changes in beneficial ownership
May 26, 2026144Notice of proposed sale of restricted securities
May 20, 20268-KCurrent report
May 04, 202610-QQuarterly report
May 04, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 04, 20268-KCurrent report
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 03, 2026DEFA14AAdditional proxy soliciting materials
Apr 03, 2026ARSAnnual report to shareholders
Apr 03, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 316
Page
▼
/ 13